Last reviewed · How we verify
NCT04431336
Young Patient With Aortic Dissection or Aneurysm: A Prospective Observational Cohort Study
trial testing movement in Aortic Aneurysm and Dissection in 100 participants. Status unknown.
30 November 2021
Quick facts
| Lead sponsor | Chinese Medical Association |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 5 June 2020 |
| Primary completion | 30 November 2021 |
| Estimated completion | 31 December 2021 |
Drugs / interventions tested
- movement
Conditions studied
- Aortic Aneurysm and Dissection — all drugs for Aortic Aneurysm and Dissection →
Sponsor
Chinese Medical Association
Who can join
Adults 1 to 50, any sex, with Aortic Aneurysm and Dissection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aortic dissection or aneurysm is unusual in young patients, and frequently associated with unusual presentations. However studies about this area is scarce. Besides, the treatment option is not clare. The prognosis of this cohort is also unclear. The goal of this study was to better understand the characters, treatment option and prognosis of young patient with aortic dissection or aneurysm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04431336
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of movement
Trials testing the same drug.
- NCT04439565 — Study on Susceptibility Genes and Pathogenic Mechanism of Non-syndromic Familial Aortic Dissection · unknown
Other recruiting trials for Aortic Aneurysm and Dissection
Currently open trials in the same condition.
- NCT07438327 — AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation · recruiting
- NCT06336213 — Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients · NA · recruiting
- NCT05434481 — MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta · NA · active not recruiting
- NCT07422129 — Multidisciplinary Analysis by Morphological and Mechanical Evaluation of the Aortic Wall in Patients Undergoing Cardiac · recruiting
Other Chinese Medical Association trials
Trials by the same sponsor.
- NCT07415473 — Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease · Phase 4 · not yet recruiting
- NCT07417696 — Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease · Phase 4 · not yet recruiting
- NCT05143593 — Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia · NA · not yet recruiting
- NCT07037264 — A Study of the Efficacy and Safety of Non-ablative Fractional Laser in the Treatment of Thyroidectomy Scars · NA · enrolling by invitation
- NCT06850246 — Safety and Effectiveness of High Frequency Electrocautery for Abdominal Fat Reduction · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04431336 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese Medical Association
- Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04431336.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing